# Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC

> **NCT02254681** · PHASE2 · TERMINATED · sponsor: **Allina Health System** · enrollment: 6 (actual)

## Conditions studied

- Intrahepatic Cholangiocarcinoma

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Cisplatin
- **RADIATION:** low dose radiotherapy

## Key facts

- **NCT ID:** NCT02254681
- **Lead sponsor:** Allina Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2018-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02254681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02254681, "Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02254681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*